top of page

EAACI 2022: Singleplex IgE test based on a mix of major allergenic molecules

Updated: Nov 22, 2022


NOVEOS SX01 by HYCOR at EAACI 2022 research by E. Potapova, P. Matricardi, et. al.
Novel NOVEOS SX01 molecular test is efficient and accurate in the screening of IgE to airborne allergies. The SX01 IgE screening test, based on a mix of major allergenic molecules from several allergen sources, may be particularly useful in the early screening of children with respiratory allergies.

An accurate allergen diagnosis can be empowering for everyone, but life-changing for the littlest among us. IgE tests are better standardized when using molecules rather than extracts. However, singleplex screening tests for food or respiratory allergies are still based on extracts.

New research for the NOVEOS system from HYCOR, validates a novel singleplex IgE screening test (NOVEOS SX01) based on a mix of major allergenic molecules, not extracts! This breakthrough approach could change how we approach early screening of children with respiratory allergies.


Scientific Poster EAACI 2022 A singleplex IgE test based on a mix of major allergenic molecules: a novel approach to the screening of respiratory allergies Authors: E. Potapova, P. Matricardi, et. al.
A singleplex IgE test based on a mix of major allergenic molecules: a novel approach to the screening of respiratory allergies Authors: E. Potapova, P. Matricardi, et. al.

Study title:

A singleplex IgE test based on a mix of major allergenic molecules: a novel approach to the screening of respiratory allergies

Authors: E. Potapova, P. Matricardi, et. al.


Objective:

To develop and validate NOVEOS SX01, a novel allergen component singleplex IgE screening test for respiratory allergies.


Conclusions:

Novel NOVEOS SX01 molecular test is efficient and accurate in the screening of IgE to airborne allergies. The SX01 IgE screening test, based on a mix of major allergenic molecules from several allergen sources, may be particularly useful in the early screening of children with respiratory allergies.


NOVEOS SX01 by HYCOR at EAACI 2022 research by E. Potapova, P. Matricardi, et. al.
In 2021, HYCOR has now added to that groundbreaking step forward by introducing the NOVEOS Screen Inhalant mix that makes use molecular allergology to improve clinical strategies for patient care.

EAACI 2022
The European Academy of Allergy and Clinical Immunology congress held on 1-3 July, 2022 at Prague, Czech Republic and online. EAACI Hybrid Congress 2022 is the world’s largest congress specializing in the field of allergy and clinical immunology.

Comments


bottom of page